Mark J. Levin, Director, 10% Owner at Fulcrum Therapeutics, Inc. (FULC), bought 5,676,488 shares at $16.00 ($1.3M) on 2019-07-22, disclosed to the SEC on 2019-07-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 5,595,238 | $0 | 0.0% |
| 2 | $16.00 | 81,250 | $1.3M | 100.0% |
| Total | $0.23 avg | 5,676,488 | $1.3M | 100% |
| Filing → |
| MLNM | SELL | 2008-01-10 | $29K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $42K | — | Filing → |
| MLNM | SELL | 2008-01-03 | $120K | — | Filing → |